Skip To Main Content
Thiago Rojas Converso on Muck Rack

Thiago Rojas Converso

As seen in: Nature, PLOS, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Thiago Rojas

Contact Thiago Rojas, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Tetrabutylammonium isolated from Anthopleura cascaia sea anemone venom (São Sebastião, Brazil) and its effects against multiresistant Klebsiella pneumoniae

|
By Leonardo De Lima, Natalia Rocha, Emidio Beraldo-Neto, Thiago Rojas Converso, Raquel Girardello, Juliana Mozer Sciani, Clara Brito Alves
| Nature Verified
Abstract The increase in bacterial resistance has been frequently observed in clinics, making the search for new antimicrobial agents necessary. In this context, marine animals represent a rich source of bioactive molecules with potential antimicrobial effects. This study evaluated the antimicrobial properties of compounds extracted from sea anemone venoms against multidrug-resistant strains of bacteria Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.
Open in Who Shared Issue with article?

Protection conferred by intraperitoneal Group A Streptococcus immunization relies on macrophages and IFN-γ but not on concurrent adaptive immune responses.

|
By Shiva Emami, Thiago Rojas Converso, Elsa Westerlund, Bengt Johansson-Lindbom
| BioRxiv
Abstract Group A Streptococcus (GAS; Streptococcus pyogenes) is an important bacterial pathogen estimated to cause over 700 million superficial infections and around 500.000 deaths due to invasive disease or severe post-infection sequelae in the world yearly. In spite of this major impact on society, there is currently no vaccine available against this bacterium.
Open in Who Shared Issue with article?

Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein

|
By Instituto Butantan, Universidade São Francisco, Thiago Rojas Converso
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Abstract Streptococcus pneumoniae is a human pathogen that colonizes the naso and/or oropharynx and can cause otitis, pneumonia, bacteremia and meningitis. To broaden the protection against pneumococcus, several pneumococcal proteins have been investigated as vaccine candidates.
Open in Who Shared Issue with article?
See all 3 articles